Sanofi-Aventis To Acquire Genzyme?

It is rumoured that multinational drugmaker Sanofi-Aventis is to acquire US-based biotechnology company Genzyme, a manufacturer of vaccines for genetic disorders and producer of drugs such as Cerezyme, a treatment for Gaucher's disease, and Fabrazyme, for Fabry disease.

To read the full article, please choose one of the following options: